We participated in the Singapore Health Product Access and Regulatory E-System (SHARE) industry briefing hosted by the Health Sciences Authority (HSA). This marks a significant milestone in Singapore’s move to digitalize and streamline regulatory submissions for health products.

🔍 Why this matters:
The 𝗦𝗛𝗔𝗥𝗘 𝘀𝘆𝘀𝘁𝗲𝗺 𝗶𝘀 𝗱𝗲𝘀𝗶𝗴𝗻𝗲𝗱 𝘁𝗼 𝗿𝗲𝗽𝗹𝗮𝗰𝗲 𝘁𝗵𝗲 𝗲𝘅𝗶𝘀𝘁𝗶𝗻𝗴 𝗠𝗘𝗗𝗜𝗖𝗦 𝗽𝗹𝗮𝘁𝗳𝗼𝗿𝗺, offering a more unified and user-friendly experience for regulatory submissions related to medical devices, therapeutic products, and other health products. For companies involved in regulatory affairs, R&D, quality assurance, and MedTech innovation, staying compliant during this transition is critical.

📅 𝗞𝗲𝘆 𝗗𝗮𝘁𝗲𝘀 𝘁𝗼 𝗥𝗲𝗺𝗲𝗺𝗯𝗲𝗿:
✅ 𝗕𝗲𝗳𝗼𝗿𝗲 𝟮𝟳 𝗝𝘂𝗻𝗲 𝟮𝟬𝟮𝟱 – Submit all urgent new applications via MEDICS
✅ 𝗕𝗲𝗳𝗼𝗿𝗲 𝟰 𝗝𝘂𝗹𝘆 𝟮𝟬𝟮𝟱 – Respond to Input Requests (IRs) on MEDICS by 5:00 PM
🛑 𝟰–𝟭𝟯 𝗝𝘂𝗹𝘆 𝟮𝟬𝟮𝟱 – Cut-over Period: No access to MEDICS; the system will be taken offline
🚀 𝟭𝟰 𝗝𝘂𝗹𝘆 𝟮𝟬𝟮𝟱 – SHARE officially goes live. All new submissions must be made through SHARE

📌 𝗔𝗰𝘁𝗶𝗼𝗻 𝗜𝘁𝗲𝗺𝘀 𝗳𝗼𝗿 𝗦𝘁𝗮𝗸𝗲𝗵𝗼𝗹𝗱𝗲𝗿𝘀:
✔️ Assign appropriate user access on CorpPass before 14 July
✔️ Conduct internal training on the SHARE system
✔️ Communicate clearly with regulatory teams about cut-off dates and transition plans
✔️ Understand that any changes made in MEDICS after 4 July will not be migrated

This transition is more than a technical upgrade — it’s a push towards more efficient, transparent, and structured health product regulation.

Let’s make sure we’re ready. ✅

A heartfelt thank you to the organizers for inviting ARQon Group, represented by Kai Li Saw, as a guest speaker at the event. We were proud to showcase our portfolio and share key insights on ASEAN registration processes and market entry strategies with a highly engaged audience of local and Chinese investors and entrepreneurs.

The event served as an important platform to:
🔹 Address core challenges in market expansion, such as compliance access, regulatory strategies, and tariff barriers
🔹 Interpret the current status and emerging trends in the eye health market
🔹 Build a space for practical experience sharing and exploring potential cross-border cooperation
🔹 Offer policy guidance for Chinese MedTech companies with overseas ambitions

The Q&A and networking sessions were especially valuable, allowing us to exchange knowledge, explore partnerships, and gain a deeper understanding of market needs from every aspect of the industry.

We were grateful for the opportunity to participate in this meaningful event and so proud to be able to support the MedTech ecosystem by building bridges across Southeast Asia.
Let's keep the momentum going!

After two intense days filled with deep tech dives and non-stop networking, the energy from hashtag#GITEXAsia2025 is still very much alive!

The days were long, but the value was undeniable — from the insights gained to the meaningful connections formed, it was truly an inspiring experience. We had the pleasure of reconnecting with visionary startups and laying the groundwork for exciting opportunities ahead.

The event brought together 500+ startups from across the globe and 250+ global investors, all under one roof, sparking discussions, deal flows, and ideas that could shape the future.

🔹 We explored the 𝗳𝘂𝘁𝘂𝗿𝗲 𝗼𝗳 𝗱𝗶𝗴𝗶𝘁𝗮𝗹 𝗵𝗲𝗮𝗹𝘁𝗵𝗰𝗮𝗿𝗲 through AI diagnostics, telemedicine, and next-gen health monitoring systems.
🔹 We gained valuable insights into the growing 𝗶𝗺𝗽𝗼𝗿𝘁𝗮𝗻𝗰𝗲 𝗼𝗳 𝗰𝘆𝗯𝗲𝗿𝘀𝗲𝗰𝘂𝗿𝗶𝘁𝘆 in today’s digital-first world.
🔹 And we witnessed firsthand how 𝗔𝗜 and 𝗿𝗼𝗯𝗼𝘁𝗶𝗰𝘀 are revolutionizing industries, streamlining operations, and reshaping our day-to-day lives.

GITEX has once again proven itself to be a true catalyst for global tech and startup innovation, now taking center stage in Asia.

The energy, ambition, and collaboration seen throughout the event were nothing short of inspiring.
The future is being built now, and we’re excited to be a part of it.

ARQon Group is proud to attend an important industry event hosted by Geneo, in collaboration with Asia Pacific Medical Technology Association (APACMed), Biotech Connection Singapore at Singapore Science Park.

As the second Trump administration introduces significant policy shifts, the biotech and medtech landscape in Asia is entering a period of geopolitical and regulatory uncertainty. This dialogue comes at a critical time to address key questions:
💡 𝗛𝗼𝘄 𝘄𝗶𝗹𝗹 𝗶𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝗼𝗻 𝗮𝗻𝗱 𝗺𝗮𝗿𝗸𝗲𝘁 𝗮𝗰𝗰𝗲𝘀𝘀 𝗯𝗲 𝗮𝗳𝗳𝗲𝗰𝘁𝗲𝗱?
💡 𝗪𝗵𝗮𝘁 𝘀𝘁𝗿𝗮𝘁𝗲𝗴𝗶𝗲𝘀 𝘄𝗶𝗹𝗹 𝗵𝗲𝗹𝗽 𝗰𝗼𝗺𝗽𝗮𝗻𝗶𝗲𝘀 𝗶𝗻 𝗔𝘀𝗶𝗮 𝘀𝘁𝗮𝘆 𝗿𝗲𝘀𝗶𝗹𝗶𝗲𝗻𝘁 𝗮𝗻𝗱 𝗰𝗼𝗺𝗽𝗹𝗶𝗮𝗻𝘁?

Valuable insights gained throughout the discussion session with thought leaders help us to strengthen our strategies for the future.

We hope that through collaboration and shared knowledge, the healthcare ecosystem in Asia can continue to thrive responsibly, sustainably, and globally.

It was a privilege to attend this impactful session, designed to elevate the standards of healthcare products and uphold patient safety through robust regulatory frameworks.

ARQon Group was proud to contribute to the discussion, with Dr. Stephen Hsu, Ph.D. presenting on 𝗚𝗼𝗼𝗱 𝗠𝗮𝗻𝘂𝗳𝗮𝗰𝘁𝘂𝗿𝗶𝗻𝗴 𝗣𝗿𝗮𝗰𝘁𝗶𝗰𝗲𝘀 (𝗚𝗠𝗣) 𝗶𝗻 𝗽𝗵𝗮𝗿𝗺𝗮𝗰𝗲𝘂𝘁𝗶𝗰𝗮𝗹 𝗾𝘂𝗮𝗹𝗶𝘁𝘆 𝗮𝘀𝘀𝘂𝗿𝗮𝗻𝗰𝗲. As a critical foundation for innovative healthcare and MedTech solutions, the presentation provided a comprehensive overview of:
✔️ 𝗙𝘂𝗻𝗱𝗮𝗺𝗲𝗻𝘁𝗮𝗹 𝗚𝗠𝗣 𝗽𝗿𝗶𝗻𝗰𝗶𝗽𝗹𝗲𝘀 that ensure consistency and control in manufacturing processes
✔️ 𝗧𝘆𝗽𝗲𝘀 𝗼𝗳 𝗶𝗻𝘀𝗽𝗲𝗰𝘁𝗶𝗼𝗻𝘀 𝗰𝗼𝗻𝗱𝘂𝗰𝘁𝗲𝗱 to uphold both local and international quality standards
✔️ 𝗧𝗵𝗲 𝗮𝗽𝗽𝗹𝗶𝗰𝗮𝘁𝗶𝗼𝗻 𝗼𝗳 𝗿𝗶𝘀𝗸-𝗯𝗮𝘀𝗲𝗱 𝗰𝗮𝘁𝗲𝗴𝗼𝗿𝗶𝘇𝗮𝘁𝗶𝗼𝗻 in identifying and addressing GMP deficiencies

The session as a whole reinforced the importance of risk management and pharmaceutical quality systems in post-market activities. It deepened our understanding of GMP and GSDP in maintaining product quality throughout the lifecycle, while also exploring post-market surveillance and enforcement measures, the structure of pharmacovigilance frameworks, and the role of critical thinking in regulatory decision-making.

Our heartfelt thanks to the organizers for the kind invitation. Every shared perspective plays a part in shaping a stronger, safer, and more compliant healthcare and MedTech ecosystem.

Thank you to the Association of Small & Medium Enterprises and Amazon Web Services (AWS) Singapore for organizing a thought-provoking and energizing event that brought together innovators, entrepreneurs, and tech enthusiasts under one roof.

One of the event's key highlights was the insightful presentations delivered by distinguished speakers Richard Goh, Valerie Leong, and Jonathan Ong, who provided structured frameworks and practical, real-world strategies for fostering innovation within organizational environments.

𝗞𝗲𝘆 𝗧𝗮𝗸𝗲𝗮𝘄𝗮𝘆𝘀 𝗧𝗵𝗮𝘁 𝗥𝗲𝘀𝗼𝗻𝗮𝘁𝗲:
🔁 “Working Backwards” Approach—A product development mindset that starts with the customer. Instead of asking, “What can we build?” the better question is, “What does the customer need?” This approach reframes innovation with clarity and intention, from FAQs to solution prototypes.

🏛️ 𝗖𝘂𝗹𝘁𝘂𝗿𝗲 𝗼𝗳 𝗜𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝗼𝗻—Innovation isn’t a one-off effort—it’s a habit, a system. It’s about removing barriers, empowering small teams, and fostering curiosity at every level of the organization.

🤖 𝗛𝗮𝗻𝗱𝘀-𝗼𝗻 𝘄𝗶𝘁𝗵 𝗚𝗲𝗻-𝗔𝗜 𝗧𝗼𝗼𝗹𝘀— Exploring Amazon’s Gen-AI capabilities wasn’t just eye-opening—it was empowering. From content generation to ideation support, AI has the potential to transform the way we work and create, especially in resource-strapped environments.

🤝 𝗡𝗲𝘁𝘄𝗼𝗿𝗸𝗶𝗻𝗴 𝘄𝗶𝘁𝗵 𝗣𝘂𝗿𝗽𝗼𝘀𝗲—The Networking Luncheon was more than just exchanging business cards. It was about connecting with like-minded individuals who share a vision of leveraging technology for meaningful impact.

This event reminded me that innovation is not just about new tools—it’s about new thinking.
Here’s to cultivating that mindset and collaborating across industries to build solutions that truly matter. 🚀

ARQon Group is honored to be selected as one of the judge panels for the BES18SM Design Challenge at the BES18 Scientific Meeting 2025. Amazing experience listening to the idea presentations by the participants. Each pitch reflected not only a technical understanding but also a strong sense of purpose to improve lives through innovation. The level of thought, creativity, and impact-driven design was truly impressive!

Warm appreciation is extended to the passionate speakers for bringing in fresh perspectives on the latest innovations in biomedical engineering, highlighting emerging trends shaping the industry, and underscoring the importance of stronger industry-academia collaborations to drive healthcare forward through innovation and partnership.

This event leaves us an inspiration, not just by the technologies being developed, but by the next generation of thinkers and problem solvers who are already making their mark!

Here's to a future of stronger connections, groundbreaking discoveries, and impactful progress in MedTech and beyond!

We’re pleased to announce the successful launch of IMDS 2025 (IMDS - International Medical Device School), our hybrid learning initiative designed to empower MedTech professionals worldwide.

Thank you to all participants and speaker, Basak Baranoglu Demirci, who joined us for the opening sessions. Your engagement and insights contributed to a dynamic and enriching start.

Key highlights from the sessions included:
✅ In-depth updates on EU MDR and IVDR
✅ Practical strategies spanning the entire MedTech product lifecycle
✅ Expert-led discussions on regulatory, quality, and commercialization pathways

This year’s program consists of 10 curated sessions, available both virtually and on-site, tailored to meet the needs of professionals navigating the evolving medical device regulatory landscape.

🎓 Participants who complete the full series will be awarded the IMDS 2025 Certificate of Completion.

🔗 Registration link: https://lnkd.in/gP7FiQUB

We look forward to your continued participation and invite you to follow us for upcoming sessions and industry insights.

Thank you to the British High Commission Singapore (UK in Singapore) for the kind invitation to the high tea networking session with the Export Support Service (ESS) team. It was a great opportunity to connect with industry peers and market advisors and explore new opportunities between the UK and Singapore.

This session marks a significant step in expanding our business journey into the UK market and building bridges with UK-based entrepreneurs. We look forward to potential partnerships and future collaborations across borders.